The growing concern about the proliferation of Zika infections in the Caribbean, Central and South America, has turned the fight against the virus in a global health emergency.
Infection is mainly transmitted through the bite of the Aedes spp mosquitoes and present symptoms like mild fever, arthralgia, myalgia, asthenia, headache and maculopapular rash clinical symptoms, plus additional symptoms like conjunctivitis, retro-orbital pain, lymphadenopathy and diarrhea.
There is widespread concern about the association of the Zika Virus with increasing cases of congenital microcephaly. Other research indicate that the virus can cause brain damage.
Certest Biotec has developed a new kit for the identification of Zika virus in patients presenting symptoms of the disease. This new “ready-for-use” product contains all the necessary components and reagents to perform a test that detects viral Zika RNA using Real Time PCR technique. It is a very important point the identification of the virus in early stages of infection; therefore, it is recommended that samples of blood, serum and/or saliva are collected during the first 5 days after the onset of symptoms.
VIASURE is a brand of Certest Biotec which develops molecular biology assays to identify pathogens causing infectious diseases by amplifying DNA fragments. The Real Time PCR technique has been turned into one of the most powerful in vitro diagnostic tool for the detection and quantification of DNA/RNA, due to its high sensitivity, reliability and good reproducibility. VIASURE currently has over 20 products for the identification of viruses, bacteria and parasites in both fecal and respiratory samples. Its composition, highly stable, allows transport at room temperature to anywhere in the world.
The new VIASURE Zika Virus Real Time PCR Detection Kit is designed for specific identification and quantification of Zika virus in clinical samples from patients with signs and symptoms of Zika virus infections.
Click for further info: VIASURE Zika Virus Real Time PCR Detection Kit
This new has been released in elEconomista (only in spanish language).
